Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mantle Cell Lymphoma; Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04692155
What this trial is testing

Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)

Who this might be right for
Mantle Cell Lymphoma
University of Alabama at Birmingham 1
Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06572618
What this trial is testing

Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
City of Hope Medical Center 27
Not applicableStudy completedNCT03053024
What this trial is testing

Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants

Who this might be right for
Lymphoma, Mantle-Cell
Xian-Janssen Pharmaceutical Ltd. 54
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT04172246
What this trial is testing

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

Who this might be right for
Mature B-cell Malignancies
BeiGene 55
Testing effectiveness (Phase 2)Ended earlyNCT02042950
What this trial is testing

A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 6
Early research (Phase 1)Ended earlyNCT01111188
What this trial is testing

Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Looking for participantsNCT07341191
What this trial is testing

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Who this might be right for
Mantle Cell Lymphoma
Canadian Cancer Trials Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115631
What this trial is testing

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Liver LymphomaMantle Cell Lymphoma
ECOG-ACRIN Cancer Research Group 360
Early research (Phase 1)Looking for participantsNCT06026319
What this trial is testing

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more
Marcela V. Maus, M.D.,Ph.D. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Testing effectiveness (Phase 2)Study completedNCT00253630
What this trial is testing

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)UnknownNCT04398953
What this trial is testing

TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)

Who this might be right for
Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 102
Post-approval studies (Phase 4)Study completedNCT02858804
What this trial is testing

EDOCH Alternating With DHAP for New Diagnosed Younger MCL

Who this might be right for
Mantle Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 55
Not applicableStudy completedNCT00712556
What this trial is testing

PET Study in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Not applicableStudy completedNCT00274794
What this trial is testing

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Who this might be right for
Lymphoma
The Cleveland Clinic 55
Next Page